说明：双击或选中下面任意单词，将显示该词的音标、读音、翻译等；选中中文或多个词，将显示翻译。
您的位置：首页 -> 词典 -> 可溶性OX40配体
1)  Soluble OX40 Ligand
可溶性OX40配体
1.
The Association of Soluble OX40 Ligand Level and Carotid Intima-Media Thickness in Coronary Heart Disease
可溶性OX40配体与颈动脉内膜中膜厚度的关系
更多例句>>
2)  OX40 ligand
OX40配体
1.
Changes of OX40 ligand expression in patients with acute coronary syndromes
急性冠脉综合征患者OX40配体表达的变化
更多例句>>
3)  Soluble CD40 Ligand
可溶性CD40配体
1.
Objective: To investigate the role of soluble CD40 ligand(sCD40L) in the pathogenesis of myasthenia gravis (MG), the concentration of sCD40L and AchRab in MG patient s serum was tested.
目的:研究重症肌无力(MG)患者血清中可溶性CD40配体(sCD40L)及抗乙酰胆碱受体抗体(AchRab)的水平,探讨sCD40L在MG发病中的作用。
2.
Methods: Besides routine detection, soluble CD40 ligand (sCD40L) and several kinds of cytokines were measured by using radioimmunoassay.
方法:除常规指标检测外,可溶性CD40配体(sCD40L)和几种细胞因子的检测采用放免分析法完成。
3.
Objective:To investigate the changes and the clinical significance of serum soluble CD40 ligand(sCD40L) contents in Patients with Diabetes nephropathy.
目的:探讨糖尿病肾病(diabetes nephropathy,DN)患者血清可溶性CD40配体(solubleCD40ligand,sCD40L)水平变化及其临床意义。
更多例句>>
4)  Soluble Fas ligand
可溶性Fas配体
1.
Objective:To study the variation of soluble serum Fas and soluble Fas Ligand in patients with aplastic anemia.
目的:探讨血清可溶性Fas(solub le Fas,sFas)和可溶性Fas配体(solub le Fas L igand,sFasL)在再生障碍性贫血(ap lasticanem ia,AA)患者血清中的变化及临床意义。
5)  sFasL
可溶性FasL配体
6)  sCD40L
可溶性CD40配体
1.
Preparation of sCD40L ELISA kit and its application;
可溶性CD40配体酶联检测试剂盒的研制及其运用
2.
The Changes and Significance of Serum sCD40L and sE-selectin in Patients with Type 2 Diabetes Mellitus;
2型糖尿病患者血清可溶性CD40配体和可溶性E-选择素的变化及临床意义
3.
Objective To observe the serum sCD40L and high-sensitive C-reactive protein level in patients with hypercholesterolemia and to study the variation of inflammatory markers after 3-week treatment with simvastatin.
目的观察高胆固醇血症患者血清可溶性CD40配体(sCD40L)及高敏C-反应蛋白(hs-CRP)水平,探讨辛伐他汀治疗3周后血清炎性标志物的变化。
更多例句>>
补充资料：[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]
分子式：C16H16ClN3O3S
分子量：365.5
CAS号：26807-65-8

性质：暂无

制备方法：暂无

用途：用于轻、中度原发性高血压。

说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条